Come up with a name for your new list and we'll add to it:
Celgen Biopharmaceuticals raised a round of funding on July 02, 2009. Investors include
China-Israel Value Capital.
Shanghai Celgen Biopharmaceutical is a bio-similar biopharmaceuticals drugs developer and manufacture in China mainly focused on Inflammation, Oncology and Metabolic Disease. Celgen's main product is …